Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Indivior ( (INDV) ).
Indivior PLC has announced a significant change in its shareholder structure, with Barclays PLC acquiring a substantial voting interest. As of July 15, 2025, Barclays holds a total of 6.33% voting rights in Indivior, marking a notable increase from its previous position below the minimum threshold. This acquisition could influence Indivior’s strategic decisions and impact its market positioning, given Barclays’ substantial influence in the financial sector.
More about Indivior
Indivior PLC is a UK-based pharmaceutical company specializing in addiction treatment products. The company focuses on developing medications primarily for opioid addiction, positioning itself as a leader in the addiction treatment market.
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.